Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Harrison

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|February 6, 2010
1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitorsAn T Vu, Stephen T Cohn, Puwen Zhang, et al.
Journal of the American College of Cardiology|September 10, 2021
Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial InfarctionXian Yu, Stephen A Newland, Tian X Zhao, et al.
Lancet (London, England)|December 19, 2012
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010Joshua A Salomon, Theo Vos, Daniel R Hogan, et al.
Lancet (London, England)|December 19, 2012
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Rafael Lozano, Mohsen Naghavi, Kyle Foreman, et al.
Lancet (London, England)|December 19, 2012
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Theo Vos, Abraham D Flaxman, Mohsen Naghavi, et al.
Lancet (London, England)|December 19, 2012
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Christopher J L Murray, Theo Vos, Rafael Lozano, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Journal of Medicinal Chemistry|February 6, 2010
1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitorsAn T Vu, Stephen T Cohn, Puwen Zhang, et al.
Journal of the American College of Cardiology|September 10, 2021
Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial InfarctionXian Yu, Stephen A Newland, Tian X Zhao, et al.
Lancet (London, England)|December 19, 2012
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010Joshua A Salomon, Theo Vos, Daniel R Hogan, et al.
Lancet (London, England)|December 19, 2012
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Rafael Lozano, Mohsen Naghavi, Kyle Foreman, et al.
Lancet (London, England)|December 19, 2012
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Theo Vos, Abraham D Flaxman, Mohsen Naghavi, et al.
Lancet (London, England)|December 19, 2012
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Christopher J L Murray, Theo Vos, Rafael Lozano, et al.
Pageof 8